Russian Team Designs Drug For Cancer Diagnostics

A team of scientists from N.I. Lobachevsky State University of Nizhny Novgorod, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, a company Amplituda Science and Technology Centre, and other research groups, has developed a combined action drug based on ionizing radiation and bacterial toxin.

The drug affects tumor cells selectively providing better diagnostics and treatment of malignant tumors. The drug consists of nano particles, as the core, with embedded radio pharmaceutical agent (a source of ionizing beta-radiation), and a highly toxic toxin derived from bacterium Pseudomonas aeruginosa.

The radio pharmaceutical agent is well secluded inside the nano particle and guarantees its side-effect-free targeted action to tumor cells.

The scientists observed that the drug not only treats, but also facilitates visualisation of the tumors, which makes it a diagnostic tool.


About Globe Market Reports

Globe Market Reports offers top class market research reports of top publishers in the industry.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s